Welcome to our dedicated page for Rezolve Ai SEC filings (Ticker: RZLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Rezolve AI plc (NASDAQ: RZLV) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a foreign private issuer. Rezolve Ai files annual reports on Form 20-F and furnishes frequent Form 6-K current reports, which together document key aspects of its AI-powered commerce business, capital structure and corporate actions.
In the supplied filings, Rezolve Ai uses Form 6-K to report on topics such as revenue guidance updates, acquisitions, financing transactions, shareholder meetings and the incorporation of external financial statements. Examples include 6-K reports describing the SmartPay asset acquisition and the Subsquid Labs GmbH share purchase agreement, the Crownpeak-related financial information, and securities purchase agreements for private placement offerings. Other 6-Ks note general meetings of shareholders, warrant exercises and the use of proceeds for sales expansion, potential accretive M&A, working capital and development of the Brain Commerce platform.
These filings complement Rezolve Ai’s press releases by providing formal details on transaction terms, consideration, registration statements on Form F-3, and the integration of exhibits such as audited financial statements and pro forma combined financial information. They also reference non-GAAP metrics like Annual Recurring Revenue (ARR), EBITDA and Adjusted EBITDA, along with risk factor discussions incorporated by reference to the company’s Form 20-F.
On Stock Titan, users can review Rezolve Ai’s 6-Ks, 20-F and related documents as they are made available through EDGAR, while AI-powered summaries help explain the significance of each filing. This includes identifying material acquisitions, capital raises, registration rights agreements and other events that shape Rezolve Ai’s position as an AI commerce and software infrastructure company. For deeper analysis, investors can also monitor how recurring revenue metrics, financing activity and corporate development initiatives appear across multiple filings over time.
Rezolve AI plc is offering 62,500,000 ordinary shares at $4.00 per share to institutional investors, for gross proceeds of $250,000,000. After paying $12,500,000 in placement agent fees and other estimated costs, the company expects net proceeds of about $237,000,000.
The cash will be used to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and for general corporate and working capital purposes. Ordinary shares outstanding were 336,327,587 as of January 13, 2026, and are expected to rise to 398,827,587 after this offering, so new investors will face immediate dilution. The shares trade on Nasdaq under the symbol “RZLV.”
Rezolve AI plc filed an amended foreign issuer report to update a key exhibit: the Placement Agent Agreement dated January 20, 2026 with A.G.P./Alliance Global Partners and Titan Partners Group LLC. The agreement appoints these firms as exclusive placement agents on a reasonable best efforts basis for a proposed placement of ordinary shares and, if applicable, pre-funded warrants.
Rezolve AI will pay a cash fee of 5.0% of aggregate gross proceeds from the sale of securities placed, plus reimbursement to A.G.P. of accountable legal and out-of-pocket expenses up to
Rezolve AI plc entered into a registered direct offering to sell 62,500,000 ordinary shares at $4.00 per share, for gross proceeds of $250.0 million before fees and expenses. The shares are being issued under an effective Form F-3 registration statement and related prospectus supplement, with closing expected on January 21, 2026, subject to customary conditions.
The company plans to use the net proceeds to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and for general corporate and working capital purposes. Rezolve AI agreed not to issue or agree to issue additional ordinary shares or equivalents, or file new registration statements, for 30 days after closing, subject to exceptions. Placement agents will receive a 5.0% cash fee on the aggregate gross proceeds plus up to $120,000 of legal fees and up to $10,000 of non-accountable expenses.
Rezolve Ai plc reported that shareholders approved all proposals at a January 13, 2026 general meeting, including authority for the board to allot shares and to disapply pre-emption rights under the UK Companies Act. The authority to allot shares covers up to a maximum aggregate nominal amount of £200,000, with 68,715,865 votes for and 17,934,811 against. The related pre-emption disapplication drew 68,708,990 votes for and 17,798,860 against.
The company also released an investor presentation highlighting a SaaS model focused on commerce-specific generative AI, more than 650 enterprise customers and over 340 million unique consumer mobile device users. The presentation cites an estimated 2025 exit annual recurring revenue of $209 million, 2026 revenue guidance of $350 million, and a targeted 2026 ARR exit rate of $500 million, supported by partnerships with Microsoft and Google, a strategic collaboration with Tether, and prior funding including $250 million of private placement in 2025.
Rezolve AI plc, a foreign private issuer based in London, furnished a Form 6-K to report that it has updated its revenue guidance for 2025 and 2026. The company disclosed that it issued a press release on January 13, 2026 outlining these revised expectations, and attached that release as an exhibit to the filing. This type of update informs investors how management currently views the company’s future revenue trajectory over the next two years.
The report is procedural in nature, with the Form 6-K mainly serving to officially provide the press release to the market and incorporate it by reference into the company’s disclosure record.
Rezolve AI plc filed a Form 6-K that primarily updates investors by furnishing financial statement exhibits related to its Crownpeak business and combined company.
The filing incorporates these materials into existing registration statements on Forms F-3 and S-8. Exhibits include audited consolidated financial statements of Crownpeak Intermediate Holdings, Inc. and subsidiaries as of January 31, 2025 and 2024, unaudited condensed consolidated Crownpeak financials for the six months ended July 31, 2025 and 2024, and unaudited pro forma condensed combined financial information for Rezolve AI plc and subsidiaries for the year ended December 31, 2024 and as of and for the six months ended June 30, 2025. Auditor consents from several firms are also provided.
Rezolve AI plc filed Prospectus Supplement No. 2 updating its previously registered mixed shelf. It continues to cover up to 7,499,994 Ordinary Shares for issuance upon exercise of Public Warrants at $11.50 per share, and up to 164,775,654 Ordinary Shares for resale by selling holders, as described in the prospectus.
The supplement updates the selling securityholders table, including the sale by Sir David Wright of 250,000 Ordinary Shares to DBLP Sea Cow Limited and the sale of 150,000 Ordinary Shares by Anthony Sharp. Resale amounts remain as previously registered and may be sold from time to time. Examples of registered resale allocations include DBLP Sea Cow Limited 26,915,689 and J.V.B. Financial Group, LLC 5,027,508. The Ordinary Shares and Public Warrants trade on Nasdaq as RZLV and RZLVW, respectively.
Rezolve AI plc filed a Rule 424(b)(3) prospectus to register the resale, from time to time, of up to 37,000,000 Ordinary Shares by selling security holders connected to its PIPE financing. Rezolve will not receive any proceeds from sales by these holders.
The registered shares were issued or are issuable under the September 2025 PIPE at $5.40 per share; the financing closed on September 25, 2025 with aggregate gross proceeds of approximately $200 million to the company at that time. The registered amount represents about 11.5% of outstanding Ordinary Shares as of the prospectus date. The Ordinary Shares trade on Nasdaq as “RZLV,” which closed at $3.85 on November 6, 2025.
The company notes that sales, or the market’s perception of potential sales, of this substantial block could increase volatility or pressure the trading price. The selling holders may have acquired shares at prices below current market levels. Distribution methods may vary as described under “Plan of Distribution.”
Rezolve AI plc filed a prospectus supplement updating a previously registered mixed offering: up to 7,499,994 Ordinary Shares for issuance upon exercise of Public Warrants at $11.50 per share, and up to 164,925,654 Ordinary Shares for resale by selling holders.
The update revises the selling securityholders table, including the sale by DBLP Sea Cow Limited of 10,600,000 Ordinary Shares as disclosed on an October 10, 2025 Schedule 13D/A. The Ordinary Shares and Public Warrants trade on Nasdaq as RZLV and RZLVW, respectively.
Rezolve AI plc filed a Form 6‑K announcing leadership changes. The company appointed Arthur Yao as Chief Operating and Financial Officer and Richard Burchill as Group Finance Director. A related press release is furnished as Exhibit 99.1.
The filing states this information is incorporated by reference into Rezolve AI’s Registration Statements on Forms F-3 (File Nos. 333-290523 and 333-290639), effective from the date of this report, unless later superseded.
FAQ
What is the current stock price of Rezolve Ai (RZLV)?
What is the market cap of Rezolve Ai (RZLV)?
